Dana-Farber Cancer Institute Sr Financial Analyst Salaries in Boulder | Comparably
Dana-Farber Cancer Institute is a center dedicated to carrying out adult and pediatric cancer treatment activities and advanced research. read more
EMPLOYEE
PARTICIPANTS
28
TOTAL
RATINGS
198

Dana-Farber Cancer Institute Sr Financial Analyst Salaries in Boulder

The average Dana-Farber Cancer Institute Sr Financial Analyst in Boulder earns $62,004 annually. This total compensation is $25,406 less than the US average for a Sr Financial Analyst.

In Boulder, The Finance Department at Dana-Farber Cancer Institute earns $3,902 more on average than the Business Development Department.

Last updated 8 months ago.

$22k
$41k
$62k
$82k
$180k
$310k
$375k
$62,004
Average Compensation
$62,004
avg. base

Sr Financial Analyst Salaries at Dana-Farber Cancer Institute

In Boulder, Sr Financial Analysts earn $5,956 more than Accountants, and $14,255 less than Senior Accountants.

Accounting Manager
$115k*
Business Analyst
$86k*
Senior Accountant
$76k*
Accountant
$56k*
* estimated salary

Compensation at Dana-Farber Cancer Institute by Department

In Boulder, The Finance Department averages $3,902 more than the Business Development Department, and $5,548 less than the Sales Department

Sales
$103,288 Avg. total comp.
+$6k
Finance
$97,740 Avg. total comp.
Business Development
$93,838 Avg. total comp.
-$4k

Sr Financial Analyst Compensation by Gender (All Companies)

The average female Sr Financial Analyst at companies similar size to Dana-Farber Cancer Institute reported making $89,840, while the average male Sr Financial Analyst at similar sized companies reported making $94,632.

Sr Financial Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Sr Financial Analyst at companies similar size to Dana-Farber Cancer Institute reported making $97,825, while the average African American/Black Sr Financial Analyst at similar sized companies reported making $68,750.

How Sr Financial Analysts at Dana-Farber Cancer Institute Rate Their Compensation

The majority of Sr Financial Analysts at Dana-Farber Cancer Institute believe they're compensated fairly. The vast majority (78%) of Sr Financial Analysts at Dana-Farber Cancer Institute are satisfied with their benefits. See more compensation ratings at Dana-Farber Cancer Institute

×
Rate your company